Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anika Therapeutics, Inc.ANIK · Entity 6005 | EVP, Human Resources | March 09, 2022 | March 11, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anika Therapeutics, Inc.
Report date March 09, 2022 · Filed March 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,598 |
Ending reported balance
After 2022-03-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-03-09 · Exercise / conversion · Acquired 2,548 · Balance 25,346 F1: Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. Row 2 · 2022-03-09 · Tax withholding · Disposed 748 · Balance 24,598 F2: Reflects an aggregate of 748 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2022. F3: Reflects the closing price of ANIK common stock on March 9, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 5,097 |
Reported balance
After 2022-03-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-09 · Exercise / conversion · Disposed 2,548 · Balance 5,097 F4: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
F2: Reflects an aggregate of 748 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2022.
F3: Reflects the closing price of ANIK common stock on March 9, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
F4: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2022 Filed Mar 11, 2022 22:36 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionRestricted Stock Unit · Derivative | 2,548 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001171843-22-001811 · ownership.xml · derivative · entry 3 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,097 Underlying: Common Stock · 2,548 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. F4 · derivative.expiration_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:36 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 748 | $26.22 | $19,612.56 |
DisclosureSEC source: 0001171843-22-001811 · ownership.xml · nonDerivative · entry 2 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,598 F2 · shares: Reflects an aggregate of 748 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2022. F3 · price: Reflects the closing price of ANIK common stock on March 9, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:36 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionCommon Stock | 2,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-22-001811 · ownership.xml · nonDerivative · entry 1 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. Read SEC document |
| February 26, 2022 Filed Feb 28, 2022 21:59 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionRestricted Stock Unit · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001171843-22-001459 · ownership.xml · derivative · entry 6 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020. F7 · derivative.expiration_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020. Read SEC document |
| February 26, 2022 Filed Feb 28, 2022 21:59 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 881 | $32.13 | $28,306.53 |
DisclosureSEC source: 0001171843-22-001459 · ownership.xml · nonDerivative · entry 4 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,798 F5 · shares: Reflects an aggregate of 881 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 26, 2022. F3 · price: Reflects the closing price of ANIK common stock on February 25, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Read SEC document |
| February 26, 2022 Filed Feb 28, 2022 21:59 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-22-001459 · ownership.xml · nonDerivative · entry 3 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects the third vesting installment of RSUs granted on February 26, 2019. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 21:59 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionRestricted Stock Unit · Derivative | 2,834 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001171843-22-001459 · ownership.xml · derivative · entry 5 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,833 Underlying: Common Stock · 2,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021. F6 · derivative.expiration_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 21:59 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 832 | $32.13 | $26,732.16 |
DisclosureSEC source: 0001171843-22-001459 · ownership.xml · nonDerivative · entry 2 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,679 F2 · shares: Reflects an aggregate of 832 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 25, 2022. F3 · price: Reflects the closing price of ANIK common stock on February 25, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 21:59 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionCommon Stock | 2,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-22-001459 · ownership.xml · nonDerivative · entry 1 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on February 25, 2020. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:28 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 3,149 | $30.72 | $96,737.28 |
DisclosureSEC source: 0001171843-22-000984 · ownership.xml · nonDerivative · entry 2 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,677 F2 · shares: Reflects an aggregate of 3,149 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to PSUs that vested on February 9, 2022. F3 · price: Reflects the closing price of the ANIK common stock on February 9, 2022, the trading day on which the vesting of PSUs gave rise to tax withholding obligations. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:28 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 10,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-22-000984 · ownership.xml · nonDerivative · entry 1 Finnerty Thomas · CIK 0001720871 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,826 F1 · shares: Reflects Performance Share Units ("PSUs") granted on February 26, 2019, and that the Compensation Committee of the Board of Directors determined on February 9, 2022 were earned. The PSUs vested in full on February 9, 2022 and were settled in shares of the Company's common stock on a one-for-one basis. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:10 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantStock Option (Right to Buy) · Derivative | 19,158 | $0.00 Strike: $37.40 | $0.00 |
DisclosureSEC source: 0001171843-21-001710 · ownership.xml · derivative · entry 2 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,158 Underlying: Common Stock · 19,158 shares Expires 2031-03-09 F2 · derivative.exercise_price: Represents a 10% premium above the closing price of Anika's common stock on the date of grant. F3 · derivative.exercise_date: The premium priced stock options vest in three equal annual installments beginning on March 9, 2022. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:10 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantRestricted Stock Unit · Derivative | 7,645 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-001710 · ownership.xml · derivative · entry 1 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,645 Underlying: Common Stock · 7,645 shares Expires not disclosed F1 · derivative.exercise_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. F1 · derivative.expiration_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:18 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionRestricted Stock Unit · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-001428 · ownership.xml · derivative · entry 6 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning on February 26, 2020. F8 · derivative.expiration_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning on February 26, 2020. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:18 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 881 | $37.57 | $33,099.17 |
DisclosureSEC source: 0001171843-21-001428 · ownership.xml · nonDerivative · entry 4 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,701 F5 · shares: Reflects an aggregate of 881 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 26, 2021. F6 · price: Reflects the closing price of the ANIK common stock on February 26, 2021, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 22:18 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-001428 · ownership.xml · nonDerivative · entry 3 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Reflects the second vesting installment of RSUs granted on February 26, 2019. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:18 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionRestricted Stock Unit · Derivative | 2,833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-001428 · ownership.xml · derivative · entry 5 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,667 Underlying: Common Stock · 2,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021. F7 · derivative.expiration_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:18 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 832 | $37.39 | $31,108.48 |
DisclosureSEC source: 0001171843-21-001428 · ownership.xml · nonDerivative · entry 2 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,582 F2 · shares: Reflects an aggregate of 832 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 25, 2021. F3 · price: Reflects the closing price of the ANIK common stock on February 25, 2021, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 22:18 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Exercise / conversionCommon Stock | 2,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-001428 · ownership.xml · nonDerivative · entry 1 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects the first vesting installment of RSUs granted on February 25, 2020. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:14 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 666 | $32.62 | $21,724.92 |
DisclosureSEC source: 0001171843-20-007517 · ownership.xml · nonDerivative · entry 1 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,581 F1 · shares: Reflects an aggregate of 666 shares of common stock retained by the Issuer to satisfy tax withholding obligations on restricted shares initially granted on October 30, 2017. F2 · price: Reflects the closing price of the ANIK common stock on October 30, 2020, the trading day on which the vesting of restricted shares occurred giving rise to tax withholding obligations. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 23:53 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 881 | $42.25 | $37,222.25 |
DisclosureSEC source: 0001171843-20-001363 · ownership.xml · nonDerivative · entry 2 Finnerty Thomas · CIK 0001720871 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,247 F2 · shares: Reflects an aggregate of 881 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 26, 2020. F3 · price: Reflects the closing price of the ANIK common stock on February 26, 2020, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 23:53 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-20-001363 · ownership.xml · nonDerivative · entry 1 Finnerty Thomas · CIK 0001720871 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,128 F1 · security: Reflects the first vesting installment of RSUs granted on February 26, 2019. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:53 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantRestricted Stock Unit · Derivative | 8,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001171843-20-001363 · ownership.xml · derivative · entry 3 Finnerty Thomas · CIK 0001720871 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021. F4 · derivative.expiration_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 20:06 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | Tax withholdingCommon Stock | 672 | $69.67 | $46,818.24 |
DisclosureSEC source: 0001171843-19-007081 · ownership.xml · nonDerivative · entry 1 Finnerty Thomas · CIK 0001720871 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,128 F1 · shares: Reflects an aggregate of 672 shares of common stock retained by the Issuer to satisfy tax withholding obligations. F2 · price: Reflects the closing price of the ANIK common stock on October 30, 2019, the trading day on which the vesting of restricted shares occurred giving rise to tax withholding obligations. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 21:33 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantStock Option (Right to Buy) · Derivative | 2,873 | $0.00 Strike: $61.47 | $0.00 |
DisclosureSEC source: 0001171843-19-001387 · ownership.xml · derivative · entry 2 Finnerty Thomas · CIK 0001720871 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,873 Underlying: Common Stock · 2,873 shares Expires 2028-01-24 F2 · derivative.exercise_price: The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 24, 2018, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 3 and 4. F3 · date: On February 27, 2019, the Compensation Committee determined and certified that 53.2% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 2 and 4. F4 · derivative.exercise_date: The stock options vest in four equal installments on the following dates: February 27, 2019, January 1, 2020, January 1, 2021, and January 1, 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:33 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantRestricted Stock Unit · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001171843-19-001387 · ownership.xml · derivative · entry 1 Finnerty Thomas · CIK 0001720871 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires not disclosed F1 · derivative.exercise_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020. F1 · derivative.expiration_date: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:07 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantStock Option (Right to Buy) · Derivative | 6,700 | $0.00 Strike: $61.47 | $0.00 |
DisclosureSEC source: 0001171843-18-000691 · formfour.xml · derivative · entry 1 Finnerty Thomas · CIK 0001720871 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,700 Underlying: Common Stock · 6,700 shares Expires 2028-01-24 F1 · derivative.exercise_date: The stock options vest in four equal annual installments beginning January 24, 2019. Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 20:11 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $54.09 | $0.00 |
DisclosureSEC source: 0001171843-17-006489 · formfour.xml · derivative · entry 2 Finnerty Thomas · CIK 0001720871 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2017-10-30 F2 · derivative.exercise_date: The stock options vest in three equal annual installments beginning October 30, 2018. Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 20:11 UTC | Anika Therapeutics, Inc. ANIK · Entity 6005 | GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-006489 · formfour.xml · nonDerivative · entry 1 Finnerty Thomas · CIK 0001720871 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,800 F1 · security: The restricted stock awards vest in three equal annual installments beginning October 30, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.